Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Radiology|April 2, 2009
Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformationsEdwin van der Linden, Peter M T Pattynama, Birthe C Heeres, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 25, 2020
Magnetic resonance assessment of sinusoidal obstruction syndrome after neoadjuvant chemotherapy for colorectal liver metastases is not reproducibleFemke Cr Staal, Regina Gh Beets-Tan, Birthe C Heeres, et al.
Physics and Imaging in Radiation Oncology|August 14, 2025
Multiparametric magnetic resonance imaging for radiotherapy response evaluation in high-risk soft tissue sarcoma: A pilot studyMilan van Meekeren, Petra J van Houdt, Marta Fiocco, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|June 15, 2022
CT-based radiomics to distinguish progressive from stable neuroendocrine liver metastases treated with somatostatin analogues: an explorative studyFemke Cr Staal, M Taghavi, Eun K Hong, et al.
Clinical and Translational Radiation Oncology|December 31, 2019
High versus low dose Stereotactic Body Radiation Therapy for hepatic metastasesEsther N D Kok, Edwin P M Jansen, Birthe C Heeres, et al.
Neuroendocrinology|June 4, 2020
Blood Molecular Genomic Analysis Predicts the Disease Course of Gastroenteropancreatic Neuroendocrine Tumor Patients: A Validation Study of the Predictive Value of the NETest®Mark J C van Treijen, Dennis van der Zee, Birthe C Heeres, et al.
Clinical Imaging|February 1, 2025
Colorectal liver metastases on gadoxetic acid-enhanced MRI: Typical characteristics decrease after chemotherapyDenise J van der Reijd, Ezgi A Soykan, Birthe C Heeres, et al.
BJU International|June 24, 2025
Evaluating follow-up in patients with lymph node-negative penile cancer at a high-volume centreManon T A Vreeburg, Gerben M Vaessen, Hielke M de Vries, et al.
Journal for Immunotherapy of Cancer|July 21, 2023
IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutationElisa A Rozeman, Judith M Versluis, Karolina Sikorska, et al.
Pageof 1